NCT02713178 - Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty | Biotech Hunter

Enrollment

232

Participants

Timeline

Start Date

June 3, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions

Pain

Interventions

DRUG

bupivacaine liposome injectable suspension

bupivacaine liposome injectable suspension 133 mg expanded with normal saline to 20 mL or 266 mg in 20 mL

DRUG

Placebo

Normal saline.

Trial Locations (17)

10467

Montefiore Medical Center, The Bronx

15701

Indiana Regional Medical Center, Indiana

15963

Chan Soon-Shiong Medical Center, Windber

19107

Thomas Jefferson University Hospital, Philadelphia

32504

Pensacola Research Associates, Pensacola

33136

Jackson Memorial Hospital/University of Miami, Miami

36608

Horizon Research Group, Inc, Mobile

77004

Hermann Drive Surgical Hospital, Houston

77027

Westside Surgical Hospital, Houston

80113

Denver Metro Orthopedics, Englewood

02115

Brigham and Women's Hospital, Boston

02215

Massachusetts General Hospital, Boston

Unknown

Fairview Hospital, Cleveland

Southampton Orthopaedics Sports Medicine, Franklin

Ziekenhuis Oost-Limburg, Genk

Aarhus University Hospital, Aarhus C

Regionshospital Silkeborg, Silkeborg